ID   GBP4_HUMAN              Reviewed;         640 AA.
AC   Q96PP9; B2R630; Q05D63; Q6NSL0; Q86T99;
DT   24-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   28-JUN-2023, entry version 162.
DE   RecName: Full=Guanylate-binding protein 4;
DE            EC=3.6.5.- {ECO:0000250|UniProtKB:P32455};
DE   AltName: Full=GTP-binding protein 4 {ECO:0000303|Ref.1};
DE            Short=GBP-4 {ECO:0000303|Ref.1};
DE   AltName: Full=Guanine nucleotide-binding protein 4;
GN   Name=GBP4 {ECO:0000303|Ref.1, ECO:0000312|HGNC:HGNC:20480};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Avdalovic A., Fu H., Tsurushita N.;
RT   "Human GBP-4 and -5: new members of the IFN-gamma-inducible guanylate
RT   binding protein family.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Spinal cord;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Spleen;
RX   PubMed=12693554; DOI=10.1093/dnares/10.1.49;
RA   Jikuya H., Takano J., Kikuno R., Hirosawa M., Nagase T., Nomura N.,
RA   Ohara O.;
RT   "Characterization of long cDNA clones from human adult spleen. II. The
RT   complete sequences of 81 cDNA clones.";
RL   DNA Res. 10:49-57(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=17266443; DOI=10.1089/jir.2007.0086;
RA   Tripal P., Bauer M., Naschberger E., Mortinger T., Hohenadl C., Cornali E.,
RA   Thurau M., Sturzl M.;
RT   "Unique features of different members of the human guanylate-binding
RT   protein family.";
RL   J. Interferon Cytokine Res. 27:44-52(2007).
RN   [7]
RP   SUBCELLULAR LOCATION, AND DIMERIZATION.
RX   PubMed=21151871; DOI=10.1371/journal.pone.0014246;
RA   Britzen-Laurent N., Bauer M., Berton V., Fischer N., Syguda A.,
RA   Reipschlager S., Naschberger E., Herrmann C., Sturzl M.;
RT   "Intracellular trafficking of guanylate-binding proteins is regulated by
RT   heterodimerization in a hierarchical manner.";
RL   PLoS ONE 5:E14246-E14246(2010).
RN   [8]
RP   UBIQUITINATION (MICROBIAL INFECTION).
RX   PubMed=29024643; DOI=10.1016/j.chom.2017.09.007;
RA   Wandel M.P., Pathe C., Werner E.I., Ellison C.J., Boyle K.B.,
RA   von der Malsburg A., Rohde J., Randow F.;
RT   "GBPs inhibit motility of Shigella flexneri but are targeted for
RT   degradation by the bacterial ubiquitin ligase IpaH9.8.";
RL   Cell Host Microbe 22:507-518(2017).
RN   [9]
RP   UBIQUITINATION (MICROBIAL INFECTION).
RX   PubMed=29144452; DOI=10.1038/nature24467;
RA   Li P., Jiang W., Yu Q., Liu W., Zhou P., Li J., Xu J., Xu B., Wang F.,
RA   Shao F.;
RT   "Ubiquitination and degradation of GBPs by a Shigella effector to suppress
RT   host defence.";
RL   Nature 551:378-383(2017).
CC   -!- FUNCTION: Interferon (IFN)-inducible GTPase that plays important roles
CC       in innate immunity against a diverse range of bacterial, viral and
CC       protozoan pathogens (By similarity). Negatively regulates the antiviral
CC       response by inhibiting activation of IRF7 transcription factor (By
CC       similarity). {ECO:0000250|UniProtKB:A4UUI3}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP + H2O = GDP + H(+) + phosphate; Xref=Rhea:RHEA:19669,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58189;
CC         Evidence={ECO:0000250|UniProtKB:P32455};
CC   -!- SUBUNIT: Heterodimer with other family members, including GBP1, GBP2
CC       and GBP5 (PubMed:21151871). Dimerization regulates subcellular location
CC       (PubMed:21151871). Interacts with IRF7; preventing interaction between
CC       TRAF6 and IRF7, resulting in impaired TRAF6-mediated IRF7
CC       ubiquitination (By similarity). {ECO:0000250|UniProtKB:A4UUI3,
CC       ECO:0000269|PubMed:21151871}.
CC   -!- INTERACTION:
CC       Q96PP9; P32455: GBP1; NbExp=2; IntAct=EBI-20840650, EBI-2869161;
CC       Q96PP9; P32456: GBP2; NbExp=2; IntAct=EBI-20840650, EBI-714388;
CC       Q96PP9; Q96PP9: GBP4; NbExp=2; IntAct=EBI-20840650, EBI-20840650;
CC       Q96PP9; Q96PP8: GBP5; NbExp=2; IntAct=EBI-20840650, EBI-749932;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:21151871}. Cytoplasm {ECO:0000269|PubMed:17266443}.
CC       Nucleus {ECO:0000269|PubMed:17266443}. Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:21151871}. Note=Heterodimers with GBP1, GBP2 and
CC       GBP5 localize in the compartment of the prenylated GBPs: with GBP1 in a
CC       vesicle-like compartment, with GBP2, around the nucleus and with GBP5,
CC       at the Golgi apparatus. {ECO:0000269|PubMed:21151871}.
CC   -!- INDUCTION: By IFNG during macrophage activation.
CC       {ECO:0000269|PubMed:17266443}.
CC   -!- PTM: (Microbial infection) Ubiquitinated by S.flexneri IpaH9.8, leading
CC       to its degradation by the proteasome, thereby preventing its ability to
CC       promote host defense against bacterial infection.
CC       {ECO:0000269|PubMed:29024643, ECO:0000269|PubMed:29144452}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class dynamin-like GTPase
CC       superfamily. GB1/RHD3 GTPase family. GB1 subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU01052}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC85144.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF288814; AAL02054.1; -; mRNA.
DR   EMBL; AL832576; CAD89936.1; -; mRNA.
DR   EMBL; AK131094; BAC85144.1; ALT_INIT; mRNA.
DR   EMBL; AK312417; BAG35327.1; -; mRNA.
DR   EMBL; BC017889; AAH17889.1; -; mRNA.
DR   EMBL; BC070055; AAH70055.1; -; mRNA.
DR   CCDS; CCDS721.1; -.
DR   RefSeq; NP_443173.2; NM_052941.4.
DR   AlphaFoldDB; Q96PP9; -.
DR   SMR; Q96PP9; -.
DR   BioGRID; 125430; 5.
DR   IntAct; Q96PP9; 4.
DR   STRING; 9606.ENSP00000359490; -.
DR   iPTMnet; Q96PP9; -.
DR   PhosphoSitePlus; Q96PP9; -.
DR   BioMuta; GBP4; -.
DR   DMDM; 116242487; -.
DR   EPD; Q96PP9; -.
DR   jPOST; Q96PP9; -.
DR   MassIVE; Q96PP9; -.
DR   MaxQB; Q96PP9; -.
DR   PaxDb; Q96PP9; -.
DR   PeptideAtlas; Q96PP9; -.
DR   ProteomicsDB; 77726; -.
DR   Antibodypedia; 33614; 231 antibodies from 29 providers.
DR   DNASU; 115361; -.
DR   Ensembl; ENST00000355754.7; ENSP00000359490.5; ENSG00000162654.9.
DR   GeneID; 115361; -.
DR   KEGG; hsa:115361; -.
DR   MANE-Select; ENST00000355754.7; ENSP00000359490.5; NM_052941.5; NP_443173.2.
DR   UCSC; uc001dnb.4; human.
DR   AGR; HGNC:20480; -.
DR   CTD; 115361; -.
DR   DisGeNET; 115361; -.
DR   GeneCards; GBP4; -.
DR   HGNC; HGNC:20480; GBP4.
DR   HPA; ENSG00000162654; Low tissue specificity.
DR   MIM; 612466; gene.
DR   neXtProt; NX_Q96PP9; -.
DR   OpenTargets; ENSG00000162654; -.
DR   PharmGKB; PA134959399; -.
DR   VEuPathDB; HostDB:ENSG00000162654; -.
DR   eggNOG; KOG2037; Eukaryota.
DR   GeneTree; ENSGT00940000164661; -.
DR   HOGENOM; CLU_018608_2_1_1; -.
DR   InParanoid; Q96PP9; -.
DR   OMA; AMEDHRQ; -.
DR   OrthoDB; 5309032at2759; -.
DR   PhylomeDB; Q96PP9; -.
DR   TreeFam; TF331602; -.
DR   PathwayCommons; Q96PP9; -.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   SignaLink; Q96PP9; -.
DR   BioGRID-ORCS; 115361; 10 hits in 1153 CRISPR screens.
DR   ChiTaRS; GBP4; human.
DR   GenomeRNAi; 115361; -.
DR   Pharos; Q96PP9; Tbio.
DR   PRO; PR:Q96PP9; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q96PP9; protein.
DR   Bgee; ENSG00000162654; Expressed in leukocyte and 146 other tissues.
DR   Genevisible; Q96PP9; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005525; F:GTP binding; IBA:GO_Central.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0071346; P:cellular response to type II interferon; IEP:UniProtKB.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IBA:GO_Central.
DR   GO; GO:0042832; P:defense response to protozoan; IBA:GO_Central.
DR   CDD; cd01851; GBP; 1.
DR   CDD; cd16269; GBP_C; 1.
DR   Gene3D; 1.20.1000.10; Guanylate-binding protein, C-terminal domain; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR030386; G_GB1_RHD3_dom.
DR   InterPro; IPR037684; GBP_C.
DR   InterPro; IPR003191; Guanylate-bd/ATL_C.
DR   InterPro; IPR036543; Guanylate-bd_C_sf.
DR   InterPro; IPR015894; Guanylate-bd_N.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR10751; GUANYLATE BINDING PROTEIN; 1.
DR   PANTHER; PTHR10751:SF17; GUANYLATE-BINDING PROTEIN 4; 1.
DR   Pfam; PF02263; GBP; 1.
DR   Pfam; PF02841; GBP_C; 1.
DR   SUPFAM; SSF48340; Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS51715; G_GB1_RHD3; 1.
PE   1: Evidence at protein level;
KW   Coiled coil; Cytoplasm; Golgi apparatus; GTP-binding; Hydrolase; Immunity;
KW   Innate immunity; Membrane; Nucleotide-binding; Nucleus; Reference proteome;
KW   Ubl conjugation.
FT   CHAIN           1..640
FT                   /note="Guanylate-binding protein 4"
FT                   /id="PRO_0000190968"
FT   DOMAIN          50..292
FT                   /note="GB1/RHD3-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01052"
FT   REGION          1..325
FT                   /note="GTPase domain (Globular)"
FT                   /evidence="ECO:0000250|UniProtKB:P32455"
FT   COILED          499..612
FT                   /evidence="ECO:0000255"
FT   BINDING         60..67
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:P32455"
FT   BINDING         82..84
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:P32455"
FT   BINDING         112..116
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:P32455"
FT   VARIANT         125
FT                   /note="K -> E (in dbSNP:rs17130745)"
FT                   /id="VAR_028283"
FT   VARIANT         379
FT                   /note="I -> V (in dbSNP:rs1831240)"
FT                   /id="VAR_028284"
FT   VARIANT         541
FT                   /note="Y -> N (in dbSNP:rs655260)"
FT                   /id="VAR_028285"
FT   VARIANT         542
FT                   /note="M -> I (in dbSNP:rs1142886)"
FT                   /id="VAR_033952"
FT   VARIANT         545
FT                   /note="M -> I (in dbSNP:rs1142889)"
FT                   /id="VAR_033953"
FT   VARIANT         545
FT                   /note="M -> L (in dbSNP:rs1142888)"
FT                   /id="VAR_033954"
FT   VARIANT         546
FT                   /note="E -> K (in dbSNP:rs1142890)"
FT                   /id="VAR_033955"
FT   VARIANT         549
FT                   /note="L -> M (in dbSNP:rs608339)"
FT                   /id="VAR_028286"
FT   VARIANT         551
FT                   /note="E -> G (in dbSNP:rs561042)"
FT                   /id="VAR_028288"
FT   VARIANT         551
FT                   /note="E -> K (in dbSNP:rs561037)"
FT                   /id="VAR_028287"
FT   CONFLICT        298
FT                   /note="E -> K (in Ref. 5; AAH70055)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        402..410
FT                   /note="IEKKKGDFV -> KKKKKKKKK (in Ref. 5; AAH17889)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        416
FT                   /note="A -> P (in Ref. 4; BAG35327)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        502
FT                   /note="A -> S (in Ref. 5; AAH70055)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        541..542
FT                   /note="YM -> NI (in Ref. 1; AAL02054 and 3; BAC85144)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        545..546
FT                   /note="ME -> LK (in Ref. 1; AAL02054 and 3; BAC85144)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        549..551
FT                   /note="LEE -> MER (in Ref. 1; AAL02054 and 3; BAC85144)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        582
FT                   /note="K -> R (in Ref. 4; BAG35327)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   640 AA;  73165 MW;  06ABFF47E615DAFC CRC64;
     MGERTLHAAV PTPGYPESES IMMAPICLVE NQEEQLTVNS KALEILDKIS QPVVVVAIVG
     LYRTGKSYLM NRLAGKRNGF PLGSTVQSET KGIWMWCVPH LSKPNHTLVL LDTEGLGDVE
     KSNPKNDSWI FALAVLLSSS FVYNSVSTIN HQALEQLHYV TELAELIRAK SCPRPDEAED
     SSEFASFFPD FIWTVRDFTL ELKLDGNPIT EDEYLENALK LIPGKNPKIQ NSNMPRECIR
     HFFRKRKCFV FDRPTNDKQY LNHMDEVPEE NLERHFLMQS DNFCSYIFTH AKTKTLREGI
     IVTGKRLGTL VVTYVDAINS GAVPCLENAV TALAQLENPA AVQRAADHYS QQMAQQLRLP
     TDTLQELLDV HAACEREAIA VFMEHSFKDE NHEFQKKLVD TIEKKKGDFV LQNEEASAKY
     CQAELKRLSE HLTESILRGI FSVPGGHNLY LEEKKQVEWD YKLVPRKGVK ANEVLQNFLQ
     SQVVVEESIL QSDKALTAGE KAIAAERAMK EAAEKEQELL REKQKEQQQM MEAQERSFQE
     YMAQMEKKLE EERENLLREH ERLLKHKLKV QEEMLKEEFQ KKSEQLNKEI NQLKEKIEST
     KNEQLRLLKI LDMASNIMIV TLPGASKLLG VGTKYLGSRI
//
